Clasado Biosciences, a developer of prebiotic ingredients and product solutions for the human gut microbiome, has shared a comment on the global health supplements market and the areas of wellbeing that brands and consumers alike are homing in on.
The business says it has seen a marked and consistent drive toward immune function in response to changing market needs, particularly in formulation development for health supplements and gummies.
Clasado has observed, owing to the increased focus on immunity throughout the COVID-19 pandemic, formulators are now putting immune function support at the top of their product development priorities.
Doug King, Director of Sales, North America, Clasado, said: “While we’re not quite ‘post-pandemic’ yet, we’re definitely seeing the market adapting to new needs and demands. One of the most pronounced changes is that consumers are far more aware of supporting their immune health and brands are responding accordingly. Interestingly, consumers are also aware of their own knowledge gaps in this regard, which gives prebiotics a huge amount of potential for formulators.
“Numerous studies have highlighted that a healthy, diverse and well-supported gut microbiome has major benefits in supporting immune health and excitingly for product developers, we’re only scratching the surface in terms of delivery method. Consumers are becoming more in tune with how to manage their everyday health proactively and supplements that support immune function through microbiome modulation look set to be the way forwards.”
The company’s own prebiotic ingredient, Bimuno, is a galactooligosaccharide (GOS) supported by more than 20 clinical trials. The business is continuously expanding its geographic reach, which now includes availability in Europe, North America, the Middle East, Australia and New Zealand.
Doug said: “We’ve passed a major tipping point in immune health – the consumer is more engaged than ever before and is proactively seeking ways to support the body’s defences.”
